✦ LIBER ✦

Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania

✍ Scribed by Streinu-Cercel, Adrian; Trifan, Anca Victorița; Căruntu, Florin Alexandru; Sporea, Ioan; Gheorghe, Liliana Simona; Curescu, Manuela; Diculescu, Mihai Mircea; Voiculescu, Mihai; Pascu, Oliviu; Lonjon-Domanec, Isabelle; Hill, Andrew Martin; Rugină, Sorin

Book ID: 121586139
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 86 KB
Volume: 13
Category: Article
ISSN: 1471-2334
DOI: 10.1186/1471-2334-13-S1-P58

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OC-26 Treatment of hepatitis C genotype

OC-26 Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the Italian telaprevir early access program

✍ Colombo, M.; Picciotto, A.; Andreone, P.; Babudieri, S.; Zuin, M.; Mazzella, G.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P1210 PREDICTORS OF SVR24 FOR 1078 PATIE

P1210 PREDICTORS OF SVR24 FOR 1078 PATIENTS WITH SEVERE FIBROSIS OR COMPENSATED CIRRHOSIS: THE INTERNATIONAL TELAPREVIR ACCESS PROGRAM

✍ Colombo, M.; Strasser, S.I.; Moreno, C.; Ferreira, P.A.; Urbanek, P.; Fernández, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Management and outcomes of side effects

Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania

✍ Streinu-Cercel, Adrian; Trifan, Anca Victorița; Căruntu, Florin Alexandru; Spore 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 88 KB

Cost-Effectiveness Comparison of Genotyp

Cost-Effectiveness Comparison of Genotype 1 Hepatitis C Virus (HCV) Treatments Using Telaprevir (TVR) in Patients with Mild Fibrosis Versus Patients with Bridging Fibrosis and Cirrhosis

✍ D’Angelo, E.R.; Gonzalez, E.; Sola, R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

806 MANAGEMENT AND OUTCOMES OF ANEMIA IN

806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTION

✍ Colombo, M.; Fernández, I.; Abdurakhmanov, D.; Ferreira, P.A.; Strasser, S.; Urb 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Safety and efficacy of triple therapy wi

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

✍ Calleja, Jose L.; Pascasio, Juan M.; Ruiz-Antorán, Belén; Gea, Francisco; Bárcen 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB